Cargando…

Ultrasound-Guided Stellate Ganglion Radiofrequency in a Patient with Ventricular Tachycardia Sensitive to Implantable Cardioverter Defibrillator: A Case Report

INTRODUCTION: Electrical storms and ventricular tachycardia are two life-threatening arrhythmias that are becoming more common. In developing ventricular arrhythmias, the sympathetic nervous system plays a vital role. Stellate ganglion (SG) block can be used in many situations as an important therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahimzadeh, Poupak, Saif, Amir-Aziz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Brieflands 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389036/ https://www.ncbi.nlm.nih.gov/pubmed/37529345 http://dx.doi.org/10.5812/aapm-123342

Ejemplares similares

Ultrasound-guided stellate ganglion block for resistant ventricular tachycardia
por: Kumar, Amarjeet, et al.
Publicado: (2017)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Epicardial Cardioverter Defibrillator Implantation due to Post-Fontan Ventricular Tachycardia
por: Papakonstantinou, Nikolaos A, et al.
Publicado: (2020)

Tachycardia detection in modern implantable cardioverter–defibrillators
por: Brüggemann, Thomas, et al.
Publicado: (2016)

Effects of ultrasound guided ganglion stellate blockade on intraoperative and postoperative hemodynamic responses in laparoscopic gynecologic surgery
por: Rahimzadeh, Poupak, et al.
Publicado: (2019)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
por: Mansour, Fadi, et al.
Publicado: (2019)

RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy
por: Tsukahara, Keita, et al.
Publicado: (2021)

Misinterpretation of dual atrioventricular nodal non-reentrant tachycardia as ventricular tachycardia and implantation of implantable cardioverter-defibrillator followed by inappropriate shocks
por: Türkmen, Yusuf
Publicado: (2020)

Arrhythmogenicity of anti-tachycardia pacing in patients with implantable cardioverter defibrillator
por: Awad, Sherien Samy, et al.
Publicado: (2023)

Dual tachycardia induced by electrocution terminated by an implantable cardioverter-defibrillator
por: Kocovic, Nikola, et al.
Publicado: (2023)

Ventricular Tachycardia Precipitated by Short-long-short Sequence in a Patient with Implantable-cardioverter Defibrillator
por: Chemello, Diego, et al.
Publicado: (2012)

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
por: Lebedeva, Viktoria K., et al.
Publicado: (2018)

Ventricular Tachycardia Storm in a Patient with an Implanted Cardioverter-Defibrillator Following COVID-19 Infection
por: Kasinadhuni, Ganesh, et al.
Publicado: (2022)

Propranolol efficiency in prevention of sustained ventricular tachycardia in patients with implanted cardioverter-defibrillator: a case series
por: Puljević, Mislav, et al.
Publicado: (2014)

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention
por: Noordman, A B P, et al.
Publicado: (2023)

Stellate Ganglion Block as Rescue Therapy in Refractory Ventricular Tachycardia
por: Rajesh, M. C., et al.
Publicado: (2017)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)
por: Aktas, Mehmet K., et al.
Publicado: (2020)

Ultrasound-guided intermuscular pocket creation for a subcutaneous implantable cardioverter-defibrillator
por: Sonoda, Yusuke, et al.
Publicado: (2021)

“Carryover phenomenon” in subcutaneous implantable cardioverter‐defibrillator: Residual energy caused early shock to subsequent ventricular tachycardia
por: Yamagishi, Yasunobu, et al.
Publicado: (2022)

Subcutaneous-implantable cardioverter defibrillator lead dislodgement in a juvenile catecholamine-induced polymorphic ventricular tachycardia patient
por: Miyoshi, Miwa, et al.
Publicado: (2022)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Radiofrequency remote monitor software patch update without cybersecurity implantable cardioverter-defibrillator firmware update increases the risk of inappropriate implantable cardioverter-defibrillator therapies
por: Qian, Xiaoxiao, et al.
Publicado: (2022)

Non-response to Implantable Cardioverter Defibrillator in a Post-Infarction Patient with Recurrent Ventricular Tachycardia After Catheter Ablation
por: Feng, Xiang-Fei, et al.
Publicado: (2015)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
por: Regoli, François D., et al.
Publicado: (2023)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Unmappable ventricular tachycardia after an old myocardial infarction. Long-term results of substrate modification in patients with an implantable cardioverter defibrillator
por: Alzand, B. S. N., et al.
Publicado: (2011)

Thoracoscopic Left Cardiac Sympathetic Denervation for a Patient with Catecholaminergic Polymorphic Ventricular Tachycardia and Recurrent Implantable Cardioverter-Defibrillator Shocks
por: Yu, Woo-Sik, et al.
Publicado: (2015)

Anesthetic management of a child with catecholaminergic polymorphic ventricular tachycardia undergoing insertion of implantable cardioverter defibrillator : a case report
por: Omiya, Keisuke, et al.
Publicado: (2020)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Venoarterial extracorporeal membrane oxygenation and implantable cardioverter-defibrillator implantation in a hemodynamically unstable infant with ventricular tachycardia from multiple cardiac rhabdomyomas
por: Kieu, Victor, et al.
Publicado: (2018)

Non-linear Association Between Body Mass Index and Ventricular Tachycardia/Ventricular Fibrillation in Patients With an Implantable Cardioverter-Defibrillator or Cardiac Resynchronization Therapy Defibrillator: A Multicenter Cohort Study
por: Zhou, Bin, et al.
Publicado: (2020)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4ss1qn3l3rjjfmkpbmd1q13to0